Search clinical trials for: SHR3824

Total 15 results

Jiangsu HengRui Medicine Co., Ltd.

Unknown

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment

Hepatic Impairment

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects

Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient

Renal Insufficiency,Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The Drug-drug Interaction of SHR3824 and SP2086

Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers (SHR3824)

Type 2 Diabetes

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-drug Interaction of SHR3824 and Metformin

Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects

Type II Diabetes
RenJi Hospital

Not yet recruiting

The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics

Myocardial Fibrosis | Obesity | Type 2 Diabetes | Magnetic Resonance Imaging | Sodium-glucose Co-transporter-2 Inhibitor
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-drug Interaction Between Simvastatin and SHR3824

Type 2 Diabetes

3

Subscribe